Urine metabolic profile changes of CCl4-liver fibrosis in rats and intervention effects of Yi Guan Jian Decoction using metabonomic approach

BMC Complementary and Alternative Medicine

Ping Liu¹  Yiyang Hu¹  Yongyu Zhang²  Wenyu Wang²  Jianye Dai²  Yu Zhao³  Jinghua Peng³  Qin Feng³  Qing Tao³  Xiaojun Gou³ 

[1] E-institute of Shanghai Municipal Education Commission, Shanghai 201203, China;Center for Traditional Chinese Medicine and Systems Biology of Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China;Institute of Liver Disease, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China

关键词: GC/MS;    Urine metabolic profiles;    Liver fibrosis;    Carbon tetrachloride;    Yi Guan Jian Decoction;   

Others  :  1229900
DOI  :  10.1186/1472-6882-13-123

 received in 2012-08-23, accepted in 2013-05-30,  发布年份 2013

【 摘 要 】

Background

Yi Guan Jian Decoction (YGJD), a famous Chinese prescription, has long been employed clinically to treat liver fibrosis. However, as of date, there is no report on the effects of YGJD from a metabonomic approach. In this study, a urine metabonomic method based on gas chromatography coupled with mass spectrometry (GC/MS) was employed to study the protective efficacy and metabolic profile changes caused by YGJD in carbon tetrachloride (CCl₄)-induced liver fibrosis.

Methods

Urine samples from Wistar rats of three randomly divided groups (control, model, and YGJD treated) were collected at various time-points, and the metabolic profile changes were analyzed by GC/MS with principal component analysis (PCA) and partial least squares-discriminate analysis (PLS-DA). Furthermore, histopathology and biochemical examination were also carried out to ensure the success of CCl₄-induced liver fibrosis model.

Results

Urine metabolic profile studies suggested distinct clustering of the three groups, and YGJD group was much closer to the control group by showing a tendency of recovering towards the control group. Fourteen significantly changed metabolites were found, and YGJD treatment could reverse the levels of these metabolites to normal levels or close to normal levels.

Conclusions

The current study indicates that the YGJD has significant anti-fibrotic effects on CCl₄-induced liver fibrosis in rats, which might be by regulating the dysfunction of energy metabolism, amino acid metabolism, tryptophan metabolism, cytochrome P450 metabolism, and gut microflora metabolism. The metabonomic approach can be recommended to study the pharmacological effect and mechanism of complex Chinese medicines.

【 授权许可】

   
2013 Gou et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

【 参考文献 】

• [1]D'Argenio G, Amoruso DC, Mazzone G, Vitaglione P, Romano A, Ribecco MT, D'Armiento MR, Mezza E, Morisco F, Fogliano V, Caporaso N: Garlic extract prevents CCl4-induced liver fibrosis in rats: the role of tissue transglutaminase. Dig Liver Dis 2010, 42(8):571-577.
• [2]Rojkind M, Giambrone MA, Biempica L: Collagen types in normal and cirrhotic liver. Gastroenterology 1979, 76(4):710-719.
• [3]Friedman SL: Liver fibrosis – from bench to beside. J Hepatol 2003, 38(Suppl 1):S38-S53.
• [4]Sun WY, Wei W, Wu L, Gui SY, Wang H: Effects and mechanisms of extract from Paeonia lactiflora and Astragalus membranaceus on liver fibrosis induced by carbon tetrachloride in rats. J Ethnopharmacol 2007, 112(3):514-523.
• [5]Veidal SS, Karsdal MA, Nawrocki A, Larsen MR, Dai Y, Zheng Q, Hägglund P, Vainer B, Skjøt-Arkil H, Leeming DJ: Assessment of proteolytic degradation of the basement membrane: a fragment of type IV collagen as a biochemical marker for liver fibrosis. Fibrogenesis Tissue Repair 2011, 4:22. BioMed Central Full Text
• [6]Zhang S, Ji G, Liu J: Reversal of chemical-induced liver fibrosis in Wistar rats by puerarin. J Nutr Biochem 2006, 17(7):485-491.
• [7]Luk JM, Wang X, Liu P, Wong KF, Chan KL, Tong Y, Hui CK, Lau GK, Fan ST: Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation. Liver Int 2007, 27(7):879-890.
• [8]Cheung KF, Ye DW, Yang ZF, Lu L, Liu CH, Wang XL, Poon RT, Tong Y, Liu P, Chen YC, Lau GK: Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats. J Ethnopharmacol 2009, 124(1):142-150.
• [9]Lin HJ, Chen JY, Lin CF, Kao ST, Cheng JC, Chen HL, Chen CM: Hepatoprotective effects of Yi Guan Jian, an herbal medicine, in rats with dimethylnitrosamine-induced liver fibrosis. J Ethnopharmacol 2011, 134(3):953-960.
• [10]Mu YP, Liu P, Long AH: Study on pathogenesis of CCl4 induced cirrhosis formation in rats based on the recipe used. Zhongguo Zhong Xi Yi Jie He Za Zhi 2006, 26(4):344-377. Chinese
• [11]Tao Q, Sun MY, Feng Q: Syndrome identification of CCl4 induced liver fibrosis model rats based on syndrome detecting from recipe used. Zhongguo Zhong Xi Yi Jie He Za Zhi 2009, 29(3):246-250. Chinese
• [12]Mu Y, Liu P, Du G, Du J, Wang G, Long A, Wang L, Li F: Action mechanism of Yi Guan Jian Decoction on CCl4 induced cirrhosis in rat. J Ethnopharmacol 2009, 121(1):35-42.
• [13]Nicholson JK, Lindon JC, Holmes E: ‘Metabonomics’: Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29(11):1181-1189.
• [14]Huang X, Gong Y, Yu K, Heng Y: Gas chromatography–mass spectrometry based on metabonomics study of carbon tetrachloride-induced acute liver injury in Mice. Chin J Analyt Chem 2007, 35(12):1736-1740.
• [15]Goldsmith P, Fenton H, Morris-Stiff G, Ahmad N, Fisher J, Prasad KR: Metabonomics: a useful tool for the future surgeon. J Surg Res 2010, 160(1):122-132.
• [16]Sun B, Li L, Wu S, Zhang Q, Li H, Chen H, Li F, Dong F, Yan X: Metabolomic analysis of biofluids from rats treated with Aconitum alkaloids using nuclear magnetic resonance and gas chromatography/time-of-flight mass spectrometry. Anal Biochem 2009, 395(2):125-133.
• [17]Dai W, Wei C, Kong H, Jia Z, Han J, Zhang F, Wu Z, Gu Y, Chen S, Gu Q, Lu X, Wu Y, Xu G: Effect of the traditional Chinese medicine tongxinluo on endothelial dysfunction rats studied by using urinary metabonomics based on liquid chromatography –mass spectrometry. J Pharm Biomed Anal 2011, 56(1):86-92.
• [18]Wu H, Liu T, Ma C, Xue R, Deng C, Zeng H, Shen X: GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization. Anal Bioanal Chem 2011, 401(2):635-646.
• [19]Wu H, Xue R, Tang Z, Deng C, Liu T, Zeng H, Sun Y, Shen X: Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry. Anal Bioanal Chem 2010, 396(4):1385-1395.
• [20]Jonsson P, Gullberg J, Nordström A, Kusano M, Kowalczyk M, Sjöström M, Moritz T: A strategy for identifying differences in large series of metabolomic samples analyzed by GC/MS. Anal Chem 2004, 76(6):1738-1745.
• [21]Major HJ, Williams R, Wilson AJ, Wilson ID: A metabonomic analysis of plasma from Zucker rat strains using gas chromatography/mass spectrometry and pattern recognition. Rapid Commun Mass Spectrom 2006, 20(22):3295-3302.
• [22]Fancy SA, Beckonert O, Darbon G, Yabsley W, Walley R, Baker D, Perkins GL, Pullen FS, Rumpel K: Gas chromatography/flame ionisation detection mass spectrometry for the detection of endogenous urine metabolites for metabonomic studies and its use as a complementary tool to nuclear magnetic resonance spectroscopy. Rapid Commun Mass Spectrom 2006, 20(15):2271-2280.
• [23]Nakamura T, Akiyoshi H, Saito I, Sato K: Adenovirus-mediated gene expression in the septal cells of cirrhotic rat livers. J Hepatol 1999, 30(1):101-106.
• [24]Jamall IS, Finelli VN, Que Hee SS: A simple method to determine nanogram levels of 4-hydroxy praline in biological tissues. Anal Biochem 1981, 112(1):70-75.
• [25]Li C, Luo J, Li L, Cheng M, Huang N, Liu J, Waalkes MP: The collagenolytic effects of the traditional Chinese medicine preparation, Han-Dan-Gan-Le, contribute to reversal of chemical-induced liver fibrosis in rats. Life Sci 2003, 72(14):1563-1571.
• [26]Qiu Y, Su M, Liu Y, Chen M, Gu J, Zhang J, Jia W: Application of ethyl chloroformate derivatization for gas chromatography–mass spectrometry based metabonomic profiling. Anal Chim Acta 2007, 583(2):277-283.
• [27]Wen H, Yoo SS, Kang J, Kim HG, Park JS, Jeong S, Lee JI, Kwon HN, Kang S, Lee DH, Park S: A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer. J Hepatol 2010, 52(2):228-233.
• [28]Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark G, Edge SB, Hayes DF, Hughes LL, Hutter RV, Morrow M, Page DL, Recht A, Theriault RL, Thor A, Weaver DL, Wieand HS, Greene FL: Revision of the American Joint Committee on cancer staging system for breast cancer. J Clin Oncol 2002, 20(17):3628-3636.
• [29]Hamza AA: Ameliorative effects of Moringa oleifera Lam seed extract on liver fibrosis in rats. Food Chem Toxicol 2010, 48(1):345-355.
• [30]Zou YH, Yang Y, Li J, Wu Q, Li WP, Lu JT, Roberts MS: Potential therapeutic effects of a traditional Chinese formulation, BJ-JN, on liver fibrosis induced by carbon tetrachloride in rats. J Ethnopharmacol 2008, 120(3):452-457.
• [31]Hsieh WT, Liu YT, Lin WC: Anti-inflammatory properties of Ajuga bracteosa in vivo and in vitro study and their effects on mouse model of liver fibrosis. J Ethnopharmacol 2011, 135(1):116-125.
• [32]Guo Y, Wu XQ, Zhang C, Liao ZX, Wu Y, Wang H: Protective effect of sodium ferulate on acetaldehyde-treated precision-cut rat liver slices. J Med Food 2012, 15(6):557-562.
• [33]Zhang X, Liu W, Niu X, An L: Systemic administration of catalpol prevents D-galactose induced mitochondrial dysfunction in mice. Neurosci Lett 2010, 473(3):224-228.
• [34]Lin Y, Si D, Zhang Z, Liu C: An integrated metabonomic method for profiling of metabolic changes in carbon tetrachloride induced rat urine. Toxicology 2009, 256(3):191-200.
• [35]Tsai MK, Lin YL, Huang YT: Effects of salvianolic acids on oxidative stress and hepatic fibrosis in rats. Toxicol Appl Pharmacol 2010, 242(2):155-164.
• [36]Singh KK: Oxidative stress, disease and cancer. London: Imperial College Press; 2006.
• [37]Zhang XL, An LJ, Bao YM, Wang JY, Jiang B: d-galactose administration induces memory loss and energy metabolism disturbance in mice: protective effects of catalpol. Food Chem Toxicol 2008, 46(8):2888-2894.
• [38]Mu YP, Liu P, Wang XL, Wang L, Du GL, Liu C, Wang GQ, Du JX, Liu Y, Li FH: Hepatic gene expression analysis of carbon tetrachloride-induced rat cirrhosis identifies Distinct Effects of Yiguanjian Decoction. World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica 2007, 9(3):43-54. Chinese
• [39]Wanless IR, Lentz JS: Fatty liver Hepatitis(steatohepatifis)and obesity: an autopsy study with analysis of risk factors. Hepatology 1990, 12(5):1106-1110.
• [40]Fiatarone JR, Coverdale SA, Batey RG, Farrell GC: Non—alcoholic steatohepatitis: impaired antipyrine metabolism and hypertriglyreridaemiamdy be clues to itspathogenesis. J Gastroenterol Hepatol 1991, 6(6):585-590.
• [41]Graf E: Antioxidant potential of ferulic acid. Free Radic Biol Med 1992, 13(4):435-448.
• [42]Ogiwara T, Satoh K, Kadoma Y, Murakami Y, Unten S, Atsumi T, Sakagami H, Fujisawa S: Radical scavenging activity and cytotoxicity of ferulic acid. Anticancer Res 2002, 22(5):2711-2717.
• [43]Verma Y, Rana SV: Gender differences in the metabolism of benzene, toluene and trichloroethylene in rat with special reference to certain biochemical parameters. J Environ Biol 2003, 24(2):135-140.
• [44]Lorenzi R, Andrades ME, Bortolin RC, Nagai R, Dal-Pizzol F, Moreira JC: Oxidative damage in the liver of rats treated with glycolaldehyde. Int J Toxicol 2011, 30(2):253-258.
• [45]Zhao X, Zhang Y, Meng X, Yin P, Deng C, Chen J, Wang Z, Xu G: Effect of a traditional Chinese medicine preparation Xindi soft capsule on rat model of acute blood stasis: a urinary metabonomics study based on liquid chromatography–mass Spectrometry. J Chromatogr B 2008, 873(2):151-158.
• [46]Huang X, Shao L, Gong Y, Mao Y, Liu C, Qu H, Cheng Y: A metabonomic characterization of CCl4-induced acute liver failure using partial least square regression based on the GC/MS metabolic profiles of plasma in mice. J Chromatogr B 2008, 870(2):178-185.
• [47]Tischler ME, Desautel M, Goldberg AL: Does Leucine, Leucyl-tRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle? J Biol Chem 1982, 257(4):1613-1621.
• [48]Ichikawa K, Okabayashi T, Shima Y, Iiyama T, Takezaki Y, Munekage M, Namikawa T, Sugimoto T, Kobayashi M, Mimura T, Hanazaki K: Branched-chain amino acid-enriched nutrients stimulate antioxidant DNA repair in a rat model of liver injury induced by carbon tetrachloride. Mol Biol Rep 2012, 39(12):10803-10.
• [49]Hernández-Muñoz R, Díaz-Muñoz M, López V, López-Barrera F, Yáñez L, Vidrio S, Aranda-Fraustro A, Chagoya de Sánchez V: Balance between oxidative damage and proliferative potential in an experimental rat model of CCl4-induced cirrhosis: protective role of adenosine administration. Hepatology 1997, 26(5):1100-1110.
• [50]Kim HY, Park J, Lee KH, Lee DU, Kwak JH, Kim YS, Lee SM: Ferulic acid protects against carbon tetrachloride-induced liver injury in mice. Toxicology 2011, 282(3):104-111.
• [51]Liu X, Zhang S, Lu X, Zheng S, Li F, Xiong Z: Metabonomic study on the anti-osteoporosis effect of Rhizoma Drynariae and its action mechanism using ultra-performance liquid chromatography-tandem mass spectrometry. J Ethnopharmacol 2012, 139(1):311-317.
• [52]Ohta Y, Sahashi D: L-tryptophan administration promotes the reversion of pre-established chronic liver injury in rats treated with carbon tetrachloride. J Nutr Biochem 2002, 13(9):550-559.
• [53]Su ZH, Li SQ, Zou GA, Yu CY, Sun YG, Zhang HW, Gu Y, Zou ZM: Urinary metabonomics study of anti-depressive effect of Chaihu-Shu-Gan-San on an experimental model of depression induced by chronic variable stress in rats. J Pharm Biomed Anal 2011, 55(3):533-539.
• [54]Rechner AR, Smith MA, Kuhnle G, Gibson GR, Debnam ES, Srai SK, Moore KP, Rice-Evans CA: Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products. Free Radic Biol Med 2004, 36(2):212-225.
• [55]Cesaro C, Tiso A, Del Prete A, Cariello R, Tuccillo C, Cotticelli G, Del Vecchio BC, Loguercio C: Gut microbiota and probiotics in chronic liver diseases. Dig Liver Dis 2011, 43(6):431-438.
• [56]Gómez-Hurtado I, Santacruz A, Peiró G, Zapater P, Gutiérrez A, Pérez-Mateo M, Sanz Y, Francés R: Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CCl4-induced fibrosis. PLoS One 2011, 6(7):e23037.
• [57]Lata J, Novotný I, Príbramská V, Juránková J, Fric P, Kroupa R, Stibůrek O: The effect of probiotics on gut flora, level of endotoxin and Child–Pugh score in cirrhotic patients: results of a double-blind randomized study. Eur J Gastroenterol Hepatol 2007, 19(12):1111-1113.